biotech
Bio-AnalystSupplement research
person

Selenium

Glucose and metabolic health

Human studies reported between-group improvement in Fasting Glucose.

Single-ingredient studies · Human studies · Includes patient groups · between-group comparison

Publications for this result: 1

Other outcomes and study details

Distinct publications linked to this topic: 8

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.

What has been studied?

Distinct human comparison papers: 2

  • Fasting Glucose

    • Comparison result:A better result than the comparison group was reported.
      Patient group · Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
  • Fasting Insulin

    • Comparison result:A better result than the comparison group was reported.
      Patient group · Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
  • HbA1c

    • Comparison result:No clear difference from the comparison group was found.
      Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Unspecified population
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
  • HOMA-IR

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Patient group · Single ingredient · varied across included studies
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Single ingredient
      • Patient group
      • Primary outcome
      • Study subject not identified
      • Timepoint: varied across included studies
      • Study comparison: selenium supplementation versus control across included randomized trials
Other measured outcomes (3)
  • metabolic syndrome

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      General population
      Measurement and study conditions
      • Review
      • Systematic review
      • Unknown intervention
      • General population
      • Secondary outcome
      • Study subject not identified
      • Timepoint: Varied across observational studies
      • Study comparison: mixed observational selenium-intake associations across six studies; not a supplementation trial
  • risk for type 2 diabetes

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      General population
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Unknown intervention
      • General population
      • Secondary outcome
      • Study subject not identified
      • Timepoint: Varied; dose-response association
      • Study comparison: Higher dietary selenium exposure above about 80 μg/day and elevated blood biomarkers associated with
  • T2D

    Research with unclear study subject or type
    • Results for this measurement were mixed; no consistent conclusion can be drawn.
      varies across included studies
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Unknown intervention
      • Unspecified population
      • Outcome role not specified
      • Between-group comparison
      • Study subject not identified
      • Timepoint: varies across included studies
      • Study comparison: higher observational selenium vs lower; RCT selenium supplementation vs placebo
Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Glucose and metabolic health

    Related papers 8 · human comparison papers 2

    View selected result
  • Cardiovascular events

    Related papers 4 · human comparison papers 2

    View results
    • Cardiovascular Mortality · Mixed results · Some studies used more than one ingredient · Some studies included patients or people with a deficiency
    • CV mortality · Improvement reported · Some studies used more than one ingredient
  • Stress and mood

    Related papers 3 · comparison findings need further review

    View results
    • beck depression inventory · Interpretation held
    • Depressive symptoms · Some studies included patients or people with a deficiency · Comparison details unconfirmed

    More outcome groups: 1

  • Exercise performance

    Related papers 2 · comparison findings need further review

    View results
    • Athletic performance · Comparison details unconfirmed
  • Blood lipids

    Related papers 1 · comparison findings need further review

    View results
    • HDL · Comparison details unconfirmed
    • HDL/TC ratio · Comparison details unconfirmed

    More outcome groups: 5

  • Bone, joint, and mobility

    Related papers 1 · comparison findings need further review

    View results
    • BMD of the lumbar region · Interpretation held
  • Cognition

    Related papers 1 · comparison findings need further review

    View results
    • mini-mental score · Some studies included patients or people with a deficiency · Comparison details unconfirmed
  • Immune and respiratory health

    Related papers 1 · comparison findings need further review

    View results
    • IFN-γ · Animal or cell research · Comparison details unconfirmed
  • Men's health

    Related papers 1 · comparison findings need further review

    View results
    • motility · Interpretation held
  • Women's health

    Related papers 1 · comparison findings need further review

    View results
    • birth weight · Some studies included patients or people with a deficiency · Comparison details unconfirmed
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 32.7 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 51

Papers linked to this topic 8 · distinct papers 8 · papers with a confirmed human comparison 2 · papers needing additional review 3

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • Fasting Glucose: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • Fasting Insulin: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • HbA1c: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • HOMA-IR: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • metabolic syndrome: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • risk for type 2 diabetes: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • T2D: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

Glucose and metabolic health

What the research found

HbA1c

No clear difference in this measurement was found between the compared groups.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fasting Glucose

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fasting Insulin

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

T2D

Results for this measurement were mixed; no consistent conclusion can be drawn.

Meta-analysis · Unknown intervention · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HOMA-IR

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

metabolic syndrome

A change was reported, but the comparison could not be confirmed.

Review · Unknown intervention · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

risk for type 2 diabetes

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled human study · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cardiovascular events

What the research found

cardiovascular mortality

Results for this measurement were mixed; no consistent conclusion can be drawn.

Controlled study in people · Ingredient combination · Deficiency group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

CV mortality

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cardiovascular mortality

The study reported improvement in this measurement.

Review · Ingredient combination · Deficiency group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cardiovascular Mortality

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Stress and mood

What the research found

depressive symptoms

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Depressive symptoms

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

postpartum depression

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

beck depression inventory

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Exercise performance

What the research found

Athletic performance

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · Unspecified population

This finding comes from animal or cell research. It does not establish the same effect in people.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood lipids

What the research found

HDL

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HDL/TC ratio

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

non-HDL-C

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TC

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TG

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

VLDL

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Bone, joint, and mobility

What the research found

BMD of the lumbar region

The study needs further checking before its result can be interpreted.

Observational study · Unknown intervention · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cognition

What the research found

mini-mental score

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Immune and respiratory health

What the research found

IFN-γ

A change was reported in animal or cell research.

Animal study · indirect · Single ingredient · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Men's health

What the research found

motility

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Women's health

What the research found

birth weight

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
0
Findings from individual and combined use, plus reviewed cautions
Key precautions
No combination cautions are available to show in the current data. This does not guarantee safety.
Review 3 combination findings and 0 findings that outperformed an ingredient alone.
These findings were reported in studies. They do not predict an individual's experience.

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

프로바이오틱스Co-supplementation with probiotics and selenium resulted in significant improvements in mental health, hormonal profiles, and oxidative stress markers compared to placebo.
코엔자임 Q10Combined supplementation with selenium and Coenzyme Q10 resulted in significantly improved renal function markers compared to placebo.
이노시톨Combined administration of myo-inositol and selenium significantly decreased TSH, TPOAb, and TgAb levels and enhanced thyroid hormones compared to baseline.